Deep Brain Stimulation Market by Application - Global Industry Analysis and Forecast to 2027

Table of Contents

1. Introduction

1.1. Report Description

1.2. Research Methodology

1.2.1. Secondary Research

1.2.2. Primary Research

2. Executive Summary

2.1. Key Highlights

3. Market Overview

3.1. Introduction

3.1.1. Market Definition

3.1.2. Market Segmentation

3.2. Market Share Analysis

3.3. Market Dynamics

3.3.1. Drivers

3.3.1.1. Rising Cases of Parkinson’s Disease Globally

3.3.1.2. Increased Awareness about Neurological Movement Disorders

3.3.2. Restraints

3.3.2.1. High Cost of the Devices

3.3.2.2. Risk of Infection at the Stimulator Site

3.3.3. Opportunities

3.3.3.1. Technological Advancements to Improve Functionality of these Devices

3.4. Industry Trends

4. Deep Brain Stimulation Market, By Application

4.1. Introduction

4.2. Deep Brain Stimulation Market Assessment and Forecast, By Application, 2017-2027

4.2.1. Parkinson’s Disease

4.2.1.1. Market Assessment and Forecast, By Region, 2017-2027 ($Million)

4.2.2. Epilepsy

4.2.2.1. Market Assessment and Forecast, By Region, 2017-2027 ($Million)

4.2.3. Obsessive-Compulsive Disorder (OCD)

4.2.3.1. Market Assessment and Forecast, By Region, 2017-2027 ($Million)

4.2.4. Dystonia

4.2.4.1. Market Assessment and Forecast, By Region, 2017-2027 ($Million)

4.2.5. Pain Management

4.2.5.1. Market Assessment and Forecast, By Region, 2017-2027 ($Million)

4.2.6. Depression

4.2.6.1. Market Assessment and Forecast, By Region, 2017-2027 ($Million)

4.2.7. Other Applications

4.2.7.1. Market Assessment and Forecast, By Region, 2017-2027 ($Million)

5. Deep Brain stimulation Market, By Region

5.1. Introduction

5.2. Deep Brain stimulation Market Assessment and Forecast, By Region, 2017-2027 ($Million)

5.3. North America

5.3.1. Market Assessment and Forecast, By Country, 2017-2027 ($Million)

5.3.2. Market Assessment and Forecast, By Application, 2017-2027 ($Million)

5.3.2.1. U.S.

5.3.2.1.1. Market Assessment and Forecast, By Application, 2017-2027 ($Million)

5.3.2.2. Canada

5.3.2.2.1. Market Assessment and Forecast, By Application, 2017-2027 ($Million)

5.3.2.3. Mexico

5.3.2.3.1. Market Assessment and Forecast, By Application, 2017-2027 ($Million)

5.4. Europe

5.4.1. Market Assessment and Forecast, By Country, 2017-2027 ($Million)

5.4.2. Market Assessment and Forecast, By Application, 2017-2027 ($Million)

5.4.2.1. Germany

5.4.2.1.1. Market Assessment and Forecast, By Application, 2017-2027 ($Million)

5.4.2.2. France

5.4.2.2.1. Market Assessment and Forecast, By Application, 2017-2027 ($Million)

5.4.2.3. UK

5.4.2.3.1. Market Assessment and Forecast, By Application, 2017-2027 ($Million)

5.4.2.4. Italy

5.4.2.4.1. Market Assessment and Forecast, By Application, 2017-2027 ($Million)

5.4.2.5. Spain

5.4.2.5.1. Market Assessment and Forecast, By Application, 2017-2027 ($Million)

5.4.2.6. Russia

5.4.2.6.1. Market Assessment and Forecast, By Application, 2017-2027 ($Million)

5.4.2.7. Rest of Europe

5.4.2.7.1. Market Assessment and Forecast, By Application, 2017-2027 ($Million)

5.5. Asia-Pacific

5.5.1. Market Assessment and Forecast, By Country, 2017-2027 ($Million)

5.5.2. Market Assessment and Forecast, By Application, 2017-2027 ($Million)

5.5.2.1. Japan

5.5.2.1.1. Market Assessment and Forecast, By Application, 2017-2027 ($Million)

5.5.2.2. China

5.5.2.2.1. Market Assessment and Forecast, By Application, 2017-2027 ($Million)

5.5.2.3. Australia

5.5.2.3.1. Market Assessment and Forecast, By Application, 2017-2027 ($Million)

5.5.2.4. India

5.5.2.4.1. Market Assessment and Forecast, By Application, 2017-2027 ($Million)

5.5.2.5. South Korea

5.5.2.5.1. Market Assessment and Forecast, By Application, 2017-2027 ($Million)

5.5.2.6. Taiwan

5.5.2.6.1. Market Assessment and Forecast, By Application, 2017-2027 ($Million)

5.5.2.7. Rest of Asia-Pacific

5.5.2.7.1. Market Assessment and Forecast, By Application, 2017-2027 ($Million)

5.6. Rest of the World

5.6.1. Market Assessment and Forecast, By Country, 2017-2027 ($Million)

5.6.2. Market Assessment and Forecast, By Application, 2017-2027 ($Million)

5.6.2.1. Brazil

5.6.2.1.1. Market Assessment and Forecast, By Application, 2017-2027 ($Million)

5.6.2.2. Turkey

5.6.2.2.1. Market Assessment and Forecast, By Application, 2017-2027 ($Million)

5.6.2.3. Saudi Arabia

5.6.2.3.1. Market Assessment and Forecast, By Application, 2017-2027 ($Million)

5.6.2.4. South Africa

5.6.2.4.1. Market Assessment and Forecast, By Application, 2017-2027 ($Million)

5.6.2.5. United Arab Emirates

5.6.2.5.1. Market Assessment and Forecast, By Application, 2017-2027 ($Million)

5.6.2.6. Others

5.6.2.6.1. Market Assessment and Forecast, By Application, 2017-2027 ($Million)

6. Company Profiles

6.1. Medtronic Plc

6.1.1. Business Overview

6.1.2. Product Portfolio

6.1.3. Key Financials

6.1.4. Strategic Developments

6.2. Boston Scientific Corporation

6.2.1. Business Overview

6.2.2. Product Portfolio

6.2.3. Key Financials

6.2.4. Strategic Developments

6.3. St. Jude Medical

6.3.1. Business Overview

6.3.2. Product Portfolio

6.3.3. Key Financials

6.3.4. Strategic Developments

6.4. Aleva Neurotherapeutics SA.

6.4.1. Business Overview

6.4.2. Product Portfolio

6.4.3. Key Financials

6.4.4. Strategic Developments

6.5. Enteromedics

6.5.1. Business Overview

6.5.2. Product Portfolio

6.5.3. Key Financials

6.5.4. Strategic Developments

6.6. Cyberonics, Inc.

6.6.1. Business Overview

6.6.2. Product Portfolio

6.6.3. Key Financials

6.6.4. Strategic Developments

6.7. Zynex

6.7.1. Business Overview

6.7.2. Product Portfolio

6.7.3. Key Financials

6.7.4. Strategic Developments

---

List of Tables

Table 1.Global Deep Brain Stimulation Market, By Application, 2017-2025($Million)
Table 2.Parkinson s Disease Market, By Region, 2017-2025($Million)
Table 3.Epilepsy Market, By Region, 2017-2025($Million)
Table 4.Obsessive-Compulsive Disorder Market, By Region, 2017-2025($Million)
Table 5.Dystonia Market, By Region, 2017-2025($Million)
Table 6.Pain Management Market, By Region, 2017-2025($Million)
Table 7.Depression Market, By Region, 2017-2025($Million)
Table 8.Other Applications Market, By Region, 2017-2025($Million)
Table 9.Deep Brain Stimulation Market, By Region, 2017-2025($Million)
Table 10.North America Deep Brain Stimulation Market, By Country, 2017-2025 ($Million)
Table 11.North America Deep Brain Stimulation Market, By Application, 2017-2025 ($Million)
Table 12.U.S. Deep Brain Stimulation Market, by Application, 2017-2025 ($Million)
Table 13.Canada Deep Brain Stimulation Market, By Application, 2017-2025 ($Million)
Table 14.Mexico Deep Brain Stimulation Market, By Application, 2017-2025 ($Million)
Table 15.Europe Deep Brain Stimulation Market, By Country, 2017-2025 ($Million)
Table 16.Europe Deep Brain Stimulation Market, By Application, 2017-2025 ($Million)
Table 17.Germany Deep Brain Stimulation Market, By Application, 2017-2025 ($Million)
Table 18.France Deep Brain Stimulation Market, By Application, 2017-2025 ($Million)
Table 19.UK Deep Brain Stimulation Market, By Application, 2017-2025 ($Million)
Table 20.Italy Deep Brain Stimulation Market, By Application, 2017-2025 ($Million)
Table 21.Spain Deep Brain Stimulation Market, By Application, 2017-2025 ($Million)
Table 22.Russia Deep Brain Stimulation Market, By Application, 2017-2025 ($Million)
Table 23.Rest of Europe Deep Brain Stimulation Market, By Application, 2017-2025 ($Million)
Table 24.Asia-Pacific Deep Brain Stimulation Market, By Country, 2017-2025 ($Million)
Table 25.Asia-Pacific Deep Brain Stimulation Market, By Application, 2017-2025 ($Million)
Table 26.Japan Deep Brain Stimulation Market, By Application, 2017-2025 ($Million)
Table 27.China Deep Brain Stimulation Market, By Application, 2017-2025 ($Million)
Table 28.Australia Deep Brain Stimulation Market, By Application, 2017-2025 ($Million)
Table 29.India Deep Brain Stimulation Market, By Application, 2017-2025 ($Million)
Table 30.South Korea Deep Brain Stimulation Market, By Application, 2017-2025 ($Million)
Table 31.Taiwan Deep Brain Stimulation Market, By Application, 2017-2025 ($Million)
Table 32.Rest of Asia-Pacific Deep Brain Stimulation Market, By Application, 2017-2025 ($Million)
Table 33.Rest of the World Deep Brain Stimulation Market, By Country, 2017-2025 ($Million)
Table 34.Rest of the World Deep Brain Stimulation Market, By Application, 2017-2025 ($Million)
Table 35.Brazil Deep Brain Stimulation Market, By Application, 2017-2025 ($Million)
Table 36.Turkey Deep Brain Stimulation Market, By Application, 2017-2025 ($Million)
Table 37.Saudi Arabia Deep Brain Stimulation Market, By Application, 2017-2025 ($Million)
Table 38.South Africa Deep Brain Stimulation Market, By Application, 2017-2025 ($Million)
Table 39.United Arab Emirates Deep Brain Stimulation Market, By Application, 2017-2025 ($Million)
Table 40.Others Deep Brain Stimulation Market, By Application, 2017-2025 ($Million)
Table 41.Medtronic Plc: Key Strategic Developments, 2017-2017
Table 42.Boston Scientific Corporation: Key Strategic Developments, 2017-2017
Table 43.St. Jude Medical: Key Strategic Developments, 2017-2017
Table 44.Aleva Neurotherapeutics SA: Key Strategic Developments, 2017-2017
Table 45.Enteromedics: Key Strategic Developments, 2017-2017
Table 46.Cyberonics, Inc.: Key Strategic Developments, 2017-2017
Table 47.Zynex: Key Strategic Developments, 2017-2017

---

List of Figures

Figure 1.Global Deep Brain Stimulation Market Share, By Application, 2017 & 2025
Figure 2 Deep Brain Stimulation Market, By Region, 2017 ($Million)
Figure 3.Medtronic Plc: Net Revenues, 2017-2017 ($Million)
Figure 4.Medtronic Plc: Net Revenue Share, By Segment, 2017
Figure 5.Medtronic Plc: Net Revenue Share, By Geography, 2017
Figure 6.Boston Scientific Corporation: Net Revenues, 2017-2017 ($Million)
Figure 7.Boston Scientific Corporation: Net Revenue Share, By Segment, 2017
Figure 8.Boston Scientific Corporation: Net Revenue Share, By Geography, 2017
Figure 9.St. Jude Medical: Net Revenues, 2017-2017 ($Million)
Figure 10.St. Jude Medical: Net Revenue Share, By Segment, 2017
Figure 11.St. Jude Medical: Net Revenue Share, By Geography, 2017
Figure 12.Aleva Neurotherapeutics SA.: Net Revenues, 2017-2017 ($Million)
Figure 13.Aleva Neurotherapeutics SA.: Net Revenue Share, By Segment, 2017
Figure 14.Aleva Neurotherapeutics SA.: Net Revenue Share, By Geography, 2017
Figure 15.Enteromedics: Net Revenues, 2017-2017 ($Million)
Figure 16.Enteromedics: Net Revenue Share, By Segment, 2017
Figure 17.Enteromedics: Net Revenue Share, By Geography, 2017
Figure 18.Cyberonics, Inc.: Net Revenues, 2017-2017 ($Million)
Figure 19.Cyberonics, Inc.: Net Revenue Share, By Segment, 2017
Figure 20.Cyberonics, Inc.: Net Revenue Share, By Geography, 2017
Figure 21.Zynex: Net Revenues, 2017-2017 ($Million)
Figure 22.Zynex: Net Revenue Share, By Segment, 2017
Figure 23.Zynex: Net Revenue Share, By Geography, 2017

Research Methodology

We use both primary as well as secondary research for our market surveys, estimates and for developing forecast. Our research process commence by analyzing the problem which enable us to design the scope for our research study. Our research process is uniquely designed with enough flexibility to adjust according to changing nature of products and markets, while retaining core element to ensure reliability and accuracy in research findings. We understand both macro and micro-economic factors to evaluate and forecast different market segments.

Data Mining

Data is extensively collected through various secondary sources such as annual reports, investor presentations, SEC filings, and other corporate publications. We also refer trade magazines, technical journals, paid databases such as Factiva and Bloomberg, industry trade journals, scientific journals, and social media data to understand market dynamics and industry trends. Further, we also conduct primary research to understand market drivers, restraints, opportunities, challenges, and competitive scenario to build our analysis.

Data Collection Matrix

Data Collection Matrix	Supply Side	Demand Side
Primary Data Sources	Manufacturers Distributors & Wholesalers GPOs	Physicians/Specialist Healthcare Providers Consumers
Secondary Data Sources	Annual Reports/SEC Filings/ Investor Presentations/ Press Releases Government/Associations Publications	Case Studies Reference Customers

 

Market Modeling and Forecasting

We use epidemiology and capital equipment-based models to forecast market size of different segments at country and regional level.

• Epidemiology-based Forecasting Model: This method uses epidemiology data gathered through various publications and from physicians to estimate population of patients, flow of treatment of individual disease and therapies. The data collected through this method includes statics on incidence of disease, population suffering from disease, and treatment population. This method is used to understand:

• Number of patients for particular device or medical procedure and
• Repeated use of particular device depending on health and condition of patient

• Capital-based Forecasting Model: This method of forecasting is based on number of replacements, installed-based and new sales of capital equipment used in various healthcare and diagnostic centers. These three parameters are calculated and forecast is developed. Installation base is calculated as average number of units per facility; while sales for particular year is calculated from number of new and replace units. Secondary data is collected through various supply chain intermediaries and opinion leaders to arrive at installation and sales rate. These techniques help our analysts in validating market and developed market estimates and forecast.

We do forecast on basis of several parameters such as market drivers, market opportunities, industry trends government regulations, raw materials supply and trade dynamics to ensure relevance of forecast with market scenario. With increasing need to granulized information, we used bottom-up methodology for forecasting where we evaluate each regional segment differently and combined all forecast to develop final market forecast.

Data Validation

We believe primary research is a very important tool in analyzing and forecasting different markets. In order to make sure accuracy of our findings, our team conducts primary interviews at every stage of research to gain deep insights into current business environment and future trends and key developments in market. This includes use of various methods such as telephonic interviews, focus groups, face to face interviews and questionnaires to validate our research from all aspects. We validate our data through primary research from key industry leaders such as CEO, product managers, marketing managers, suppliers, distributors, and consumers are frequently interviewed. These interviews provide valuable insights which help us to have better market understanding besides validating our estimates and forecast.

Data Triangulation

Industry Analysis

Qualitative Data	Quantitative Data (2017-2025)
Market Dynamics (Drivers, Restraints, and Challenges) Industry Trend Analysis Market Opportunities Government Policies and Regulations, Patent Analysis, and Reimbursement Policies Porter’s Five Forces and PESTLE Analysis Key Developments and Competitive Landscape	Market Assessment and Forecast Market Assessment and Forecast, By Product Market Assessment and Forecast, By Technology Market Assessment and Forecast, By Application Market Assessment and Forecast, By End User Market Assessment and Forecast, By Region/Country